Uncluding chronic lymphocystis leukomija 17 p deletion (CLL)
Vkakoi strane v Evrope proischodet kliniceskij... - CLL Support
Vkakoi strane v Evrope proischodet kliniceskije ispytanije s IBRUTINIB ( CLL 17p deletion)
Written by
deimante
To view profiles and participate in discussions please or .
Read more about...
4 Replies
•
HAIRBEAR_UKFounder Admin
Hi
lahko prevesti v Englkish tožbenih
Can you translate into English please ?
Google identifies Slovenian but fails to translate in full? Without this we cannot understand your question?
Nick
MsLockYourPostsPassed Volunteer
Is there, perhaps someone here who could translate the question if it were posted? Calling all translators!
CllcanadaTop Poster CURE Hero
I believe that the question asks when ibrutinib will be available in the EU for 17p deleted CLL.
The answer...unknown.
I think we all want to know when ibrutinib will be avaliable for general use.
Not what you're looking for?
You may also like...
Venetoclax (ABT-199) Receives Breakthrough Therapy Designation In Relapsed Or Refractory CLL In Previously Treated 17p deletion Patients
This breakthrough designation - only for relapsed/refractory 17p deletion patients should mean the...
Anyone know if CLL 10 trial (FCR v Ibrutinib+R) is open for recruitment anywhere in UK?
Saw my consultant today and, unsurprisingly (given my recently enlarged spleen and neck nodes, and...
Zanubrutinib looks promising on all fronts in first interim analysis of ALPINE Trial - Ibrutinib v Zanubrutinib in R/R CLL - report from EHA
Dr Pete Hillmen (UK) reported on this at EHA on 11th June 2021
Background
First-generation BTK...
